• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TRACON Pharmaceuticals, Inc. - Common Stock (NQ:TCON)

1.430 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TRACON Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
December 14, 2022
  On Wednesday, 115 stocks hit new 52-week lows. 
Via Benzinga
News headline image
TRACON Shares Ascend On FDA Fast Track Status To Soft Tissue Cancer Candidate ↗
September 14, 2022
The U.S. 
Via Benzinga
News headline image
TRACON Secures FDA Nod For Early-Stage Study In Soft-Tissue Cancer ↗
August 29, 2022
 
Via Benzinga
News headline image
TRACON Seeks FDA Nod For Initial-Stage Tissue Cancer Study ↗
August 08, 2022
TRACON Pharmaceuticals (NASDAQ: TCON) has submitted an Investigational New Drug (IND) application to the U.S. 
Via Benzinga
News headline image
TRACON Touts Encouraging Objective Response Rates For Mid-Stage Cancer Study ↗
December 14, 2022
 
Via Benzinga
News headline image
TRACON Pharmaceuticals Announces Positive Results Based on Double-Digit Objective Response Rate in Each Cohort from the Ongoing ENVASARC Phase 2 Pivotal Trial
December 14, 2022
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Envafolimab and Doxorubicin in Front Line Sarcoma
November 21, 2022
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
TRACON Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 14, 2022 ↗
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
News headline image
TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗
November 07, 2022
The Dow Jones jumped by over 400 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around... 
Via Benzinga
News headline image
TRACON to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 14, 2022
October 31, 2022
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗
October 20, 2022
The Dow Jones dropped by around 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange ↗
October 08, 2022
Beijing AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising just $20 million, which netted the company only $10 million. Interest in the offering was low, with less than 1% of the... 
Via Talk Markets
News headline image
TRACON Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Aggressively Buying ↗
October 06, 2022
US gold futures traded slightly higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
News headline image
Runway Growth Finance Corp. Provides Third Quarter 2022 Portfolio Update
October 06, 2022
From Runway Growth Finance Corp.
Via GlobeNewswire
News headline image
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of 12 Week Safety Data from ENVASARC Phase 2 Pivotal Trial - Trial to Proceed as Planned
October 06, 2022
Review of Interim Efficacy Data by IDMC to Occur in Fourth Quarter 
From TRACON Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗
October 05, 2022
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks. 
Via InvestorPlace
News headline image
$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying ↗
October 04, 2022
The Dow Jones jumped by more than 750 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
Cyclo Therapeutics, TRACON Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
September 23, 2022
The Dow Jones dropped by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary ↗
September 14, 2022
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
September 14, 2022
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
August 30, 2022
  
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
August 30, 2022
It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news on Tuesday morning. 
Via InvestorPlace
News headline image
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗
August 10, 2022
 
Via Benzinga
News headline image
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Recap of Monday's Biotech Catalysts - End Of the Day Summary ↗
August 08, 2022
 
Via Benzinga
News headline image
BitNile And 1 Other Stock Under $2 Insiders Are Aggressively Buying ↗
July 18, 2022
Bank of America (NYSE: BAC) reported weaker-than-expected results for its second quarter. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More ↗
June 28, 2022
U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗
June 27, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 24, 2022
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap